Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07517588Not ApplicableNot Yet Recruiting

EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)

Role: lead

NCT04666467Not ApplicableWithdrawn

Early Feasibility Study of the PLAR Implant and Delivery System to Treat Functional Mitral Regurgitation ( EXPLORE FMR )

Role: lead

NCT04666480Not ApplicableTerminated

Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation

Role: lead

NCT04098328Terminated

Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation

Role: lead

NCT06113354Not ApplicableNot Yet Recruiting

EXPLORE MRace: Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant

Role: lead

NCT04679714Not ApplicableNot Yet Recruiting

EXPLORE FMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Functional Mitral Regurgitation

Role: lead

NCT04679662Not ApplicableNot Yet Recruiting

EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation

Role: lead

All 7 trials loaded